Market Tracker

05/27 5:16pm ET

DexCom Inc (NASDAQ:DXCM)

65.29
Delayed Data
As of May 27
 +2.14 / +3.39%
Today’s Change
47.92
Today|||52-Week Range
103.29
-20.28%
Year-to-Date
Sohn Picks Revisited: Mixed Results From David Einhorn & Jeffrey Smith
May 23 / TheStreet.com - Paid Partner Content
Better Buy: MannKind Corp. vs. Dexcom
May 20 / MotleyFool.com - Paid Partner Content
3 Stocks We Like -- but Not for Retirees
May 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close63.15
Today’s open63.07
Day’s range62.30 - 65.43
Volume1,037,592
Average volume (3 months)899,577
Market cap$5.4B
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-140.00%
Earnings growth (this year)-37.78%
Earnings growth (next 5 years)+32.50%
Revenue growth (last year)+55.09%
P/E ratioNM
Price/Sales16.26
Price/Book24.00

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...+0.88+1.19%
ABMDAbiomed Inc+0.94+0.95%
IARTIntegra LifeSciences...+0.78+1.07%
NUVANuVasive Inc+1.64+3.08%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$402.0M
Annual profit (last year)-$57.6M
Net profit margin-14.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Kevin Ronald Sayer
Senior Vice President-
Operations
Jeffrey C. Moy
Corporate headquarters
San Diego, California

Forecasts